Literature DB >> 24511127

Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients.

Else van den Berg1, Andreas Pasch2, Welmoet H Westendorp3, Gerjan Navis4, Elizabeth J Brink5, Reinold O B Gans6, Harry van Goor3, Stephan J L Bakker7.   

Abstract

In post-transplant conditions, sulfur may be protective by intermediate conversion to hydrogen sulfide and thiosulfate. However, sulfate, the end product of sulfur-containing amino acids (SAAs), contributes to metabolic acid load and may adversely influence acid-base homeostasis. We investigated the association of urinary sulfur metabolites with cardiometabolic parameters in renal transplant recipients (RTRs) and analyzed their predictive capacity for mortality. We studied urinary sulfate and thiosulfate excretion in 24-hour urine samples from 707 RTRs at a median 5.4 years (interquartile range, 1.9 to 12.2) after transplantation as well as from 110 controls. Diet was assessed for SAA content and various risk factors were measured. Urinary sulfate was similar, whereas thiosulfate was higher in RTRs versus controls. SAA intake was lower in RTRs compared with controls and correlated with sulfate but not thiosulfate excretion. Sulfate beneficially associated with eGFR, net acid excretion, systolic BP, high-sensitivity C-reactive protein, N-terminal probrain natriuretic peptide, and proteinuria (all P≤0.01). Thiosulfate beneficially associated with eGFR, serum acidity, high-sensitivity C-reactive protein, and N-terminal probrain natriuretic peptide (all P≤0.001). During a median 27 months (interquartile range, 22-36) of follow-up, 47 RTRs died. After adjustment for age, sex, and eGFR, hazard ratios for mortality were 0.87 (95% confidence interval, 0.82 to 0.92; P<0.001) for urinary sulfate and 0.60 (95% confidence interval, 0.41 to 0.59; P=0.01) for thiosulfate. Thus, despite the association of urinary sulfate with metabolic acid load, urinary sulfate and thiosulfate beneficially associated with survival in RTRs, possibly by influencing cardiovascular parameters. Intervention studies with exogenous sulfur are warranted to elucidate mechanisms underlying these promising associations in RTRs.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24511127      PMCID: PMC4033367          DOI: 10.1681/ASN.2013050497

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

Review 1.  Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.

Authors:  H A Kreis; C Ponticelli
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

2.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

3.  Relationship of dietary intake of sulphur amino-acids to urinary excretion of inorganic sulphate in man.

Authors:  Z I Sabry; S B Shadarevian; J W Cowan; J A Campbell
Journal:  Nature       Date:  1965-05-29       Impact factor: 49.962

4.  Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography.

Authors:  G L Newton; R Dorian; R C Fahey
Journal:  Anal Biochem       Date:  1981-07-01       Impact factor: 3.365

5.  Dietary protein, blood pressure and renal function in renal transplant recipients.

Authors:  Else van den Berg; Mariëlle F Engberink; Elizabeth J Brink; Marleen A van Baak; Rijk O B Gans; Gerjan Navis; Stephan J L Bakker
Journal:  Br J Nutr       Date:  2012-08-21       Impact factor: 3.718

Review 6.  Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential.

Authors:  Chang-qing Chen; Hong Xin; Yi-zhun Zhu
Journal:  Acta Pharmacol Sin       Date:  2007-11       Impact factor: 6.150

7.  Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury.

Authors:  Eelke M Bos; Henri G D Leuvenink; Pauline M Snijder; Niels J Kloosterhuis; Jan-Luuk Hillebrands; Jaklien C Leemans; Sandrine Florquin; Harry van Goor
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

8.  Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol.

Authors:  G I Feunekes; W A Van Staveren; J H De Vries; J Burema; J G Hautvast
Journal:  Am J Clin Nutr       Date:  1993-10       Impact factor: 7.045

9.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

10.  Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.

Authors:  Ali Abbasi; Linda M Peelen; Eva Corpeleijn; Yvonne T van der Schouw; Ronald P Stolk; Annemieke M W Spijkerman; Daphne L van der A; Karel G M Moons; Gerjan Navis; Stephan J L Bakker; Joline W J Beulens
Journal:  BMJ       Date:  2012-09-18
View more
  28 in total

1.  C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.

Authors:  Michele F Eisenga; Marco van Londen; David E Leaf; Ilja M Nolte; Gerjan Navis; Stephan J L Bakker; Martin H de Borst; Carlo A J M Gaillard
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  The fate of sulfate in chronic heart failure.

Authors:  Anne M Koning; Wouter C Meijers; Isidor Minović; Adrian Post; Martin Feelisch; Andreas Pasch; Henri G D Leuvenink; Rudolf A de Boer; Stephan J L Bakker; Harry van Goor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

3.  Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.

Authors:  Camilo G Sotomayor; António W Gomes-Neto; Marco van Londen; Rijk O B Gans; Ilja M Nolte; Stefan P Berger; Gerjan J Navis; Ramón Rodrigo; Henri G D Leuvenink; Casper G Schalkwijk; Stephan J L Bakker
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-17       Impact factor: 8.237

4.  Calcification Propensity and Survival among Renal Transplant Recipients.

Authors:  Charlotte A Keyzer; Martin H de Borst; Else van den Berg; Willi Jahnen-Dechent; Spyridon Arampatzis; Stefan Farese; Ivo P Bergmann; Jürgen Floege; Gerjan Navis; Stephan J L Bakker; Harry van Goor; Ute Eisenberger; Andreas Pasch
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

Review 5.  Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.

Authors:  Kalani L Raphael
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

6.  Urine Anion Gap to Predict Urine Ammonium and Related Outcomes in Kidney Disease.

Authors:  Kalani L Raphael; Sarah Gilligan; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 8.237

7.  Hydrogen Sulfide and the Kidney.

Authors:  Balakuntalam S Kasinath; Hak Joo Lee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

9.  Mediterranean Style Diet and Kidney Function Loss in Kidney Transplant Recipients.

Authors:  António W Gomes-Neto; Maryse C J Osté; Camilo G Sotomayor; Else van den Berg; Johanna Marianna Geleijnse; Stefan P Berger; Reinold O B Gans; Stephan J L Bakker; Gerjan J Navis
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 8.237

10.  Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.

Authors:  Adrian Post; Alexander Bollenbach; Stephan J L Bakker; Dimitrios Tsikas
Journal:  Amino Acids       Date:  2021-03-02       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.